infection control
Showing 51 - 75 of >10,000
Latent Tuberculosis Infection Trial (Recombinant Mycobacterium Tuberculosis Fusion Protein, Purified Protein Derivative of
Not yet recruiting
- Latent Tuberculosis Infection
- Recombinant Mycobacterium Tuberculosis Fusion Protein
- Purified Protein Derivative of Tuberculin
- (no location specified)
Jun 8, 2023
SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)
Recruiting
- SARS-CoV-2 Infection
- COVID-19 mRNA Vaccine (ZSVG-02-O)
- COVID-19 Vaccine (Vero Cell) ,Inactivated
-
Dengfeng, Henan, China
- +1 more
Nov 6, 2023
Treatment Compliance Trial in Karachi (to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli
Recruiting
- Treatment Compliance
- to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli infection
-
Karachi, Sindg, Pakistan
- +1 more
Oct 6, 2022
Infection Primary Trial in Cairo (herbal intracanal medication paste, Meta paste)
Recruiting
- Infection Primary
- herbal intracanal medication paste
- Meta paste
-
Cairo, Bani Suif, EgyptNUB University
Dec 10, 2022
Surgical Site Infection, Surgical Wound Infection, Surgery--Complications Trial in Birmingham, Chester (drug, device, other)
Recruiting
- Surgical Site Infection
- +3 more
- 2% alcoholic chlorhexidine skin prep (SKIN PREP)
- +3 more
-
Birmingham, United Kingdom
- +1 more
Nov 21, 2022
Healthcare Workers & Infection Control in University & COVID-19
Completed
- Coronavirus Disease (COVID-19)
-
Cairo, Non-US, EgyptFaculty of Medicine Ain Shams University Research Institute- Cli
Apr 17, 2021
Carbapenem-Resistant Enterobacteriaceae Infection Trial in Haifa (FMT)
Completed
- Carbapenem-Resistant Enterobacteriaceae Infection
- FMT
-
Haifa, IsraelRambam Health Care Campus
Nov 22, 2022
Urinary Tract Infections (UTIs) Trial (Urex Plus - containing L. rhamnosus GR-1 and L. reuteri RC-14, Placebo - capsule with no
Withdrawn
- Urinary Tract Infections (UTIs)
- Urex Plus - containing L. rhamnosus GR-1 and L. reuteri RC-14
- Placebo - capsule with no active ingredient
- (no location specified)
Nov 7, 2022
Chikungunya Virus Infection Trial (VLA1553 full dose, VLA1553 half dose, Control)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553 full dose
- +2 more
- (no location specified)
Oct 24, 2023
Urinary Retention, Catheter-Associated Urinary Tract Infection, Catheter Complications Trial in Las Palmas De Gran Canaria,
Not yet recruiting
- Urinary Retention
- +2 more
- Foley catheter
- T-Control catheter
-
Las Palmas De Gran Canaria, Las Palmas, Spain
- +1 more
Dec 1, 2022
Urinary Tract Infections Trial (Long Intervention, Mid-length Intervention, Short Intervention)
Not yet recruiting
- Urinary Tract Infections
- Long Intervention
- +2 more
- (no location specified)
Feb 6, 2023
Wound, Wound Heal, Wound Infection Trial in Giza (laser therapy for wound management)
Completed
- Wound
- +2 more
- laser therapy for wound management
-
Giza, EgyptKasr Al Aini University Hospital
May 8, 2023
Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Hepatitis E Virus Infection Trial in Hanzhou
Active, not recruiting
- Human Papilloma Virus Infection Type 16
- +2 more
- Cecolin
- Hecolin
-
Hanzhou, Zhejiang, ChinaZhejiang Provincial Center for Disease Control and Prevention
Jun 8, 2022
Infection Control, Antibiotic Prophylaxis Trial in Malmö (Amoxicillin, Placebo)
Completed
- Infection Control
- Antibiotic Prophylaxis
- Amoxicillin
- Placebo
-
Malmö, SwedenMalmö university
Aug 19, 2021
Seasonal Influenza and Pneumococcal Vaccination in the Elderly
Recruiting
- Immunization; Infection
- +3 more
-
Ankara, Çankaya, TurkeyLokman Hekim University
Dec 22, 2022
Streptococcus Pneumoniae Infection Trial in China (13-valent pneumococcal conjugate vaccine (multivalent conjugate), Prevenar
Recruiting
- Streptococcus Pneumoniae Infection
- 13-valent pneumococcal conjugate vaccine (multivalent conjugate)
- Prevenar 13
-
Hechi City, Guangxi Zhuang Autonomous Region, China
- +4 more
Feb 26, 2023
mNGS for Therapy of Urinary Infectious Diseases
Not yet recruiting
- Urinary Tract Infections
- Sequelae of; Infection
- mNGS of urine cell-free DNA
- (no location specified)
Nov 20, 2022
Diabetic Patient (Type 1,2, MODY, Secondary) or With Corticosteroid-induced Diabetes Following Initiation of Corticosteroid
Terminated
- Diabetic Patient (Type 1,2, MODY, Secondary) or With Corticosteroid-induced Diabetes Following Initiation of Corticosteroid Treatment
- Continuous blind glucose measurement device (Free style Pro)
-
Strasbourg, FranceHopitaux Universitaires de Strasbourg
Apr 19, 2022
Type 2 Diabetes, COVID-19 Trial in Al Kharj (Tele physical therapy, Patient educationa and Conventional exercises)
Completed
- Type 2 Diabetes Mellitus
- COVID-19
- Tele physical therapy
- Patient educationa and Conventional exercises
-
Al Kharj, Riyadh, Saudi ArabiaGopal Nambi
Oct 29, 2022
Helicobacter Pylori Infection Trial in Santiago (Optimized bismuth quadruple therapy, Control)
Recruiting
- Helicobacter Pylori Infection
- Optimized bismuth quadruple therapy
- Control
-
Santiago, Metropolitana, Chile
- +1 more
Dec 21, 2022
Evaluation of HIV-1 Recent Infection Testing in Rwanda
Recruiting
- HIV Infections
- Return of recent classification
- Return of long-term classification
-
Kigali, RwandaRwanda Biomedical Centre, Ministry of Health
May 9, 2022
HPV Vaccination on HPV Infection and Cervical Related Disease
Not yet recruiting
- HPV Infection
- Cervical Disease
- Questionnaire Survey and Cervical Cancer Screening
- (no location specified)
Apr 24, 2022
HIV Trial in Chennai, Tamil Nadu (psychoeducational, control)
Withdrawn
- HIV Infections
- psychoeducational
- control
-
Chennai, Tamil Nadu, IndiaYRG Care
Sep 19, 2022
Chronic Hepatitis b Trial in Adelaide (Therapeutic hepatitis B vaccine, Commercial Hepatitis B vaccine)
Not yet recruiting
- Chronic Hepatitis b
- Therapeutic hepatitis B vaccine
- Commercial Hepatitis B vaccine
-
Adelaide, South Australia, AustraliaFlinders University
Mar 7, 2022
Antimicrobial Stewardship, Drug Resistance, Bacterial Trial in Nanoro, Kimpese (Behavioural intervention bundle to optimise
Enrolling by invitation
- Antimicrobial Stewardship
- Drug Resistance, Bacterial
- Behavioural intervention bundle to optimise antibiotic use and reduce the risk of human-to-human or environmental-animal-human transmission
-
Nanoro, Burkina Faso
- +1 more
Jun 8, 2022